Patent US4828563A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4828563A Expired / Lapsed US ⏱️ 0.0 years remaining

Implant

Assignee: DR MULLER-LIERHEIM AG BEHRINGSTRASSE 6 8033 PLANEGG WEST GERMANY
•
Filing: 1987-08-13
•
Granted: 1989-05-09
•
Expires: 2007-08-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An implant having a surface coating of growth factors for animal or human cells, wherein the growth factors are covalently bonded to bonding-active groups of a polymer on the base body of the implant.

Inventors

  • 👤 Wolfgang G. K. Muller-Lierheim

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:13
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/38; A61L27/14; A61L27/22; A61L27/227; A61L27/50; A61L27/54; A61L2300/00; A61L2300/20; A61L2300/252; A61L2300/256; A61L2300/40; A61L2300/412; A61L2300/414; A61L2300/60; A61L2300/606

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 74 words
An implant comprising: a rigid, implantable base body; a polymer layer anchored to the surface of said base body, said polymer layer having bonding-active groups at least on a polymer surface thereof remote from said base body polyclonal antibodies bonded to said polymer surface by said bonding-active groups; and growth factors for animal cells including bone substance-inducing proteins bound to said polyclonal antibodies, wherein said polyclonal antibodies are receptors for said bone substance-inducing proteins.
Claim 2
Dependent Claim 74 words
An implant comprising: a rigid, implantable base body; a polymer layer anchored to the surface of said base body, said polymer layer having bonding-active groups at least on a polymer surface thereof remote from said base body polyclonal antibodies bonded to said polymer surface by said bonding-active groups; and growth factors for animal cells including bone substance-inducing proteins bound to said polyclonal antibodies, wherein said polyclonal antibodies are receptors for said bone substance-inducing proteins.
Claim 3
Dependent Claim 17 words
An implant as set forth in claim 1 wherein said growth factors are animal cell metabolism products.
Claim 4
Dependent Claim 15 words
An implant as set forth in claim 1 wherein said growth factors include blood serum.
Claim 5
Dependent Claim 19 words
An implant as set forth in claim 1 wherein said growth factors include at least one blood serum constituent.
Claim 6
Dependent Claim 14 words
An implant as set forth in claim 3 wherein said growth factors include fibronectin.
Claim 7
Dependent Claim 24 words
An implant as set forth in claim 1 wherein said growth factors include a combination of cell metabolism product and biochemically modified natural product.
Claim 8
Dependent Claim 18 words
An implant as set forth in claim 1 wherein said growth factors include protein leading to cell differentiation.
Claim 9
Dependent Claim 20 words
An implant as set forth in claim 7 wherein said growth factors are in the form of bone powder extract.
Claim 10
Dependent Claim 23 words
An implant as set forth in claim 8 wherein said bone powder extract is bonded with an extracellular matrix to said polymer surface.
Claim 11
Dependent Claim 15 words
An implant as set forth in claim 1 wherein said polymer surface has oxirane groups.
Claim 12
Dependent Claim 31 words
An implant as set forth in claim 1 wherein said polymer is a copolymer comprising at least two monomers selected from the group consisting of methacrylate, N-methylene-bis-methacrylamide, allylglycidyl ether and glycidylmethacrylate.
Claim 13
Dependent Claim 14 words
An implant as set forth in claim 1 wherein said base body comprises metal.
Claim 14
Dependent Claim 16 words
An implant as set forth in claim 1 wherein said base body has anchoring means thereon.
Claim 15
Dependent Claim 24 words
An implant as set forth in claim 13 wherein said anchoring means comprise projections forming undercut configurations at the surface of said base body.
Claim 16
Dependent Claim 82 words
A bone implant comprising: a rigid, implantable base body; a polymer layer anchored to the surface of said base body, said polymer layer having bonding-active groups on a polymer surface remote from said base body; and polyclonal antibodies bonded to said polymer surface by said bonding-active groups, said polyclonal antibodies being receptor for bone substance-inducing proteins; wherein, upon implantation of said bone implant in an animal or human body, said polyclonal antibodies absorb bone substance-inducing proteins from the environment in the body.
Claim 17
Dependent Claim 82 words
A bone implant comprising: a rigid, implantable base body; a polymer layer anchored to the surface of said base body, said polymer layer having bonding-active groups on a polymer surface remote from said base body; and polyclonal antibodies bonded to said polymer surface by said bonding-active groups, said polyclonal antibodies being receptor for bone substance-inducing proteins; wherein, upon implantation of said bone implant in an animal or human body, said polyclonal antibodies absorb bone substance-inducing proteins from the environment in the body.

References Cited (Backward Citations)

US3983000A Cited
US4071409A Cited
US4164794A Cited
US4565784A Cited
US4451568A Cited
US4458678A Cited
US4505266A Cited
US4542069A Cited
US4568706A Cited
US4608052A Cited
DE3519073A1 Cited
US4598122A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-05-08 1992-11-07 1993-05-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-05-08 1996-11-07 1997-05-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-05-08 2000-11-07 2001-05-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag